Antimicrobial peptides: A promising tool to combat multidrug resistance in SARS CoV2 era.

Saini, Jasleen; Kaur, Pritpal; Malik, Naveen; Lakhawat, Sudarshan Singh; Sharma, Pushpender Kumar

Saini, Jasleen; Kaur, Pritpal; Malik, Naveen; Lakhawat, Sudarshan Singh; Sharma, Pushpender Kumar.

Afiliación

Saini J; Department of Biotechnology, Sri Guru Granth Sahib World University, Fatehgarh Sahib, Punjab, India.
Kaur P; Department of Biotechnology, Sri Guru Granth Sahib World University, Fatehgarh Sahib, Punjab, India.
Malik N; Amity Institute of Biotechnology, Amity University Rajasthan, Jaipur, India.
Lakhawat SS; Amity Institute of Biotechnology, Amity University Rajasthan, Jaipur, India.
Sharma PK; Amity Institute of Biotechnology, Amity University Rajasthan, Jaipur, India. Electronic address: pksharma@jpr.amity.edu.

Microbiol Res ; 265: 127206, 2022 Dec.

Article en En | MEDLINE | ID: mdl-36162150

Asunto(s)

Tratamiento Farmacológico de COVID-19; SARS-CoV-2; Péptidos Antimicrobianos; Antivirales/farmacología; Resistencia a Múltiples Medicamentos; Humanos; Pandemias

Palabras clave

Antimicrobial peptide; Antimicrobial resistance; Antiviral peptides; Severe acute respiratory syndrome coronavirus

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / Tratamiento Farmacológico de COVID-19 Límite: Humans Idioma: En Revista: Microbiol Res Asunto de la revista: MICROBIOLOGIA / SAUDE AMBIENTAL Año: 2022 Tipo del documento: Article País de afiliación: India

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google